Dahabreh, Dante http://orcid.org/0000-0002-4050-6773
Jung, Seungyeon http://orcid.org/0000-0001-8407-9411
Renert-Yuval, Yael http://orcid.org/0000-0002-2876-3048
Bar, Jonathan http://orcid.org/0000-0001-7366-9416
Del Duca, Ester http://orcid.org/0000-0001-7948-8536
Guttman-Yassky, Emma http://orcid.org/0000-0002-9363-324X
Article History
Accepted: 25 June 2023
First Online: 22 August 2023
Declarations
:
: Not applicable.
: Emma Guttman-Yassky is an employee of Mount Sinai, has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, Medimmune/Astra Zeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, UCB, and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. Dante Dahabreh, Seungyeon Jung, Yael Renert-Yuval, Jonathan Bar, and Ester Del Duca declare that they have no conflicts of interest to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DD: first author, writer, editor, organization, and concept planning for all sections of review of the manuscript; developed Table InternalRef removed and Fig. InternalRef removed. SJ: writer and editor, and contributed to 30% of the text; developed Table InternalRef removed. YR-Y: editor for the paper, and cross-source checking. JB: editor for the paper, and cross-source checking; table design. EDD: editor for content, and concept check. EG-Y: editor and concept organization. All authors read and approved the final manuscript.